Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis

AIDS Research and Human Retroviruses(2022)10.1089/aid.2021.0232Source: DataRank Database

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Ex-Vivo Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis is a research paper published in AIDS Research and Human Retroviruses (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Topics (17)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Alberto C. Guardo,Luis M. Bedoya ORCID,Cristina Rodríguez de Miguel ORCID,Núria Climent ORCID,Cristina Rovira ORCID

Live enrichment

PubMed:36416229 PMC:PMC10325810

NIAID NIH HHS

Grant: P30 AI050410

MeSH Terms

HumansHIV InfectionsRitonavirAnti-HIV AgentsHomosexuality, MaleMalePost-Exposure ProphylaxisLopinavirEmtricitabineRaltegravir PotassiumSexual and Gender MinoritiesMaraviroc

Keywords

HIVPreventionMaravirocPostexposure ProphylaxisRectal Explants